Aisen PS - Search Results

1

Commentary on "Biomarkers in Alzheimer's disease drug development." Can't live without 'em.

Aisen PS. Aisen PS. Alzheimers Dement. 2011 May;7(3):e48-50. doi: 10.1016/j.jalz.2010.06.006. Alzheimers Dement. 2011. PMID: 21575868 Free PMC article. No abstract available.

2

Leon Thal and the therapeutic age of Alzheimer's disease.

Aisen PS. Aisen PS. Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S4-6. doi: 10.1016/j.jalz.2007.12.001. Alzheimers Dement. 2008. PMID: 18631999 No abstract available.

3

Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease.

Fleisher AS, Raman R, Siemers ER, Becerra L, Clark CM, Dean RA, Farlow MR, Galvin JE, Peskind ER, Quinn JF, Sherzai A, Sowell BB, Aisen PS, Thal LJ. Fleisher AS, et al. Among authors: aisen ps. Arch Neurol. 2008 Aug;65(8):1031-8. doi: 10.1001/archneur.65.8.1031. Arch Neurol. 2008. PMID: 18695053 Free PMC article. Clinical Trial.

4

Recent developments in Alzheimer's disease therapeutics.

Rafii MS, Aisen PS. Rafii MS, et al. Among authors: aisen ps. BMC Med. 2009 Feb 19;7:7. doi: 10.1186/1741-7015-7-7. BMC Med. 2009. PMID: 19228370 Free PMC article. Review.

5

Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Facilitating Alzheimer's disease drug development in the United States.

Aisen PS. Aisen PS. Alzheimers Dement. 2009 Mar;5(2):125-7. doi: 10.1016/j.jalz.2009.01.005. Alzheimers Dement. 2009. PMID: 19328440 Free PMC article. No abstract available.

6

MRI substudy participation in Alzheimer disease (AD) clinical trials: baseline comparability of a substudy sample to entire study population.

Raman R, Thomas RG, Weiner MW, Jack CR, Ernstrom K, Aisen PS, Tariot PN, Quinn JF. Raman R, et al. Among authors: aisen ps. Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):333-6. doi: 10.1097/WAD.0b013e3181aba588. Alzheimer Dis Assoc Disord. 2009. PMID: 19571733 Free PMC article. Clinical Trial.

7

Alzheimer's disease therapeutic research: the path forward.

Aisen PS. Aisen PS. Alzheimers Res Ther. 2009 Jul 9;1(1):2. doi: 10.1186/alzrt2. Alzheimers Res Ther. 2009. PMID: 19674435 Free PMC article.

8

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.

Trojanowski JQ, Vandeerstichele H, Korecka M, Clark CM, Aisen PS, Petersen RC, Blennow K, Soares H, Simon A, Lewczuk P, Dean R, Siemers E, Potter WZ, Weiner MW, Jack CR Jr, Jagust W, Toga AW, Lee VM, Shaw LM; Alzheimer's Disease Neuroimaging Initiative. Trojanowski JQ, et al. Among authors: aisen ps. Alzheimers Dement. 2010 May;6(3):230-8. doi: 10.1016/j.jalz.2010.03.008. Alzheimers Dement. 2010. PMID: 20451871 Free PMC article. Review.

9

Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans.

Aisen PS, Petersen RC, Donohue MC, Gamst A, Raman R, Thomas RG, Walter S, Trojanowski JQ, Shaw LM, Beckett LA, Jack CR Jr, Jagust W, Toga AW, Saykin AJ, Morris JC, Green RC, Weiner MW; Alzheimer's Disease Neuroimaging Initiative. Aisen PS, et al. Alzheimers Dement. 2010 May;6(3):239-46. doi: 10.1016/j.jalz.2010.03.006. Alzheimers Dement. 2010. PMID: 20451872 Free PMC article. Review.

10

Requiring an amyloid-beta1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials.

Schneider LS, Kennedy RE, Cutter GR; Alzheimer’s Disease Neuroimaging Initiative. Schneider LS, et al. Alzheimers Dement. 2010 Sep;6(5):367-77. doi: 10.1016/j.jalz.2010.07.004. Alzheimers Dement. 2010. PMID: 20813339 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

602 results

Search Page